Hyamedix ApS

Private limited companyCVR 39177749FrederiksbergActive

Hyamedix ApS is a private limited company, based in Frederiksberg, active in manufacture of basic pharmaceutical products, founded in 2017. Equity was negative at the end of 2025 (−DKK 10.1m). Measured by gross profit, it ranks no. 10 of 14 companies in the industry in the database. The company made a loss in both 2024 and 2025, most recently DKK 887k.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 1.8m+5,224.4% vs. 2024
Net profit−DKK 887k+35.3% vs. 2024
Equity−DKK 10.1m−9.7% vs. 2024
Employees2latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • The loss got smaller: from DKK 1.4m to DKK 887k (2024 → 2025).

Management and owners, last 24 months

  • New owners registered: Ginnerup Capital ApS (17/09/2026).
  • No longer registered as owner: Ginnerup Capital ApS (16/09/2026).

Registrations, last 24 months

  • 17/09/2026: Share capital changed from 46,252 DKK to 46,583 DKK
  • 08/05/2026: Share capital changed from 45,591 DKK to 46,252 DKK
  • 13/01/2026: Share capital changed from 44,269 DKK to 45,591 DKK

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 12m−DKK 10m−DKK 8m−DKK 6m−DKK 4m−DKK 2mDKK 0DKK 2m202020212022202320242025
EquityNet profit
Financial figures for Hyamedix ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit1,402−2,705−2,13448−361,843+5,224.4%
Operating profit (EBIT)–––––157–
Profit before tax−486−5,825−5,207−2,452−2,474−836+66.2%
Net profit−486−5,974−5,207−2,751−1,371−887+35.3%
Total assets2,2513,5611,8534,4842,3011,576−31.5%
Equity1,523−3,855−5,052−7,803−9,173−10,060−9.7%
Liabilities7297,4176,90612,28711,47411,636+1.4%
Cash and cash equivalents2,0903,3811,6513,381738266−63.9%
Average number of employees3332220%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 5mDKK 0DKK 5mDKK 10mDKK 15mDKK 20mDKK 25m202020212022202320242025
Gross profitMedian, the industry (14 companies)

Signals from the financial statements

calculated from the 2025 figures
  • Negative equity

    Equity was −DKK 10.1m at the end of 2025.

    How is this calculated?

    Equity in the latest annual report is below zero.

  • Loss for 6 years in a row

    Net result has been negative in 2020–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Hyamedix ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202529/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202408/07/2025The companyPDFXBRL
202301/01/2023 – 31/12/202328/06/2024The companyPDFXBRL
202201/01/2022 – 31/12/202230/06/2023The companyPDFXBRL
202101/01/2021 – 31/12/202124/06/2022The companyPDFXBRL
202001/01/2020 – 31/12/202026/04/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0112208/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

14 companies in the database

Comparison with the other companies in manufacture of basic pharmaceutical products based on the latest financial year.

Gross profitDKK 1.8mNo. 10 of 14
Better than 31% of the companies in the industry
Equity−DKK 10.1mNo. 14 of 14
Better than 0% of the companies in the industry
Number of employees2No. 12 of 14
Better than 15% of the companies in the industry

Industry median: gross profit DKK 13.9m, net profit DKK 80,789, equity DKK 10.1m, 19 employees.

DKK 100kDKK 749kDKK 5.6mDKK 42mDKK 161mHere
Distribution of gross profit for 14 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 32,641of 69,742
Better than 53%
No. 69,591of 69,964
Better than 1%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 17,680of 33,588
Better than 47%
No. 33,355of 33,687
Better than 1%
All companies of type ApS66,508 companies in the comparison
No. 31,600of 66,379
Better than 52%
No. 66,125of 66,505
Better than 1%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Manufacture of basic pharmaceutical products
Gross profit
  1. Hyamedix ApSDKK 1.8m
  2. Xellia Pharmaceuticals ApSDKK 314.9m
  3. Glycom Manufacturing A/SDKK 226.3m
Net profit
  1. Hyamedix ApS−DKK 887k
  2. Xellia Pharmaceuticals ApSDKK 213.7m
  3. Glycom Manufacturing A/SDKK 69.2m
Equity
  1. Hyamedix ApS−DKK 10.1m
  2. Xellia Pharmaceuticals ApSDKK 404.6m
  3. Glycom Manufacturing A/SDKK 577.7m

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
Hyamedix ApS

Management

6 active registrations

Executive management

Executive management at Hyamedix ApS
NameRoleAppointed
Michael Foldager JohansenCEO15/12/2017
Birgit FuhlendorffDirector22/09/2023
Khadija Schwach-AbdellaouiDirector22/09/2023

Board of directors

Board of directors at Hyamedix ApS
NameRoleAppointed
Michael Foldager JohansenChair of the board15/12/2017
Jesper Ahlmann Funding AndersenDeputy chair11/12/2020
Khadija Schwach-AbdellaouiBoard member22/09/2023
Founders
Vivida ApS, Hyaworth ApS, Huang Zhe
Former management (3)
Former management at Hyamedix ApS
NameRoleAppointedResigned
Todd Andrew KenworthCEO15/12/201722/09/2023
Todd Andrew KenworthChair of the board15/12/201722/09/2023
Timothy James EvistonBoard member24/09/202110/06/2022

Signing rule: Selskabet tegnes af to medlemmer af bestyrelsen i forening eller af et medlem af bestyrelsen i forening med en direktør eller af den samlede bestyrelse.

Address and production units

1 active production units

Nordre Fasanvej 215
2000 Frederiksberg

Frederiksberg Municipality · Postcode 2000

Other companies at the address (8)

  • Sparrow Quantum ApSManufacture of computers and peripheral equipment
  • Adcendo ApSResearch and experimental development on natural sciences and engineering
  • Hemab ApSManufacture of pharmaceutical preparations
  • Orbis Medicines ApSResearch and experimental development on natural sciences and engineering
  • Minervax ApSResearch and experimental development on natural sciences and engineering
Production units
Production unitAddressEmployeesP number
Hyamedix ApSNordre Fasanvej 215, 2000 Frederiksberg21023159550

Purpose

Selskabets formål er at eje teknologier til udlicensiering eller eje kapitalandele i andre virksomheder samt enhver hermed beslægtet virksomhed og drift.

The purpose is quoted from the register in Danish.

Changes year by year

50 registered events
20266 changescapital 3 · ownership 2 · accounts 1
  • Share capital changed from 46,252 DKK to 46,583 DKK
  • Ginnerup Capital ApS registered as owner (20%)
  • Ginnerup Capital ApS is no longer registered as owner
  • Annual report for 2025 published
  • Share capital changed from 45,591 DKK to 46,252 DKK
  • Share capital changed from 44,269 DKK to 45,591 DKK
20251 changeaccounts 1
  • Annual report for 2024 published
20243 changesaccounts 1 · address 2
  • Annual report for 2023 published
  • Moved to Nordre Fasanvej 215, 2000 Frederiksberg
  • Moved to Fruebjergvej 3, 2100 København Ø
202311 changesmanagement 5 · ownership 5 · accounts 1
  • Birgit Fuhlendorff appointed director
  • Khadija Schwach-Abdellaoui appointed director
  • Khadija Schwach-Abdellaoui appointed board member
  • Todd Andrew Kenworth stepped down as chair of the board
  • Todd Andrew Kenworth stepped down as ceo
  • Ginnerup Capital ApS registered as owner (15%)
  • Ginkgo ApS registered as owner (5%)
  • Jafa Holding ApS registered as owner (5%)
  • GoQing Ltd. registered as owner (5%)
  • Hyaworth ApS is no longer registered as owner
  • Annual report for 2022 published
20228 changescapital 2 · accounts 1 · management 1 · ownership 4
  • Share capital changed from 44,232 DKK to 44,269 DKK
  • Annual report for 2021 published
  • Timothy James Eviston stepped down as board member
  • Share capital changed from 42,733 DKK to 44,232 DKK
  • Michael Foldager Johansen registered as owner (33.33%)
  • Michael Foldager Johansen is no longer registered as owner
  • Todd Andrew Kenworth registered as owner (33.33%)
  • Todd Andrew Kenworth is no longer registered as owner
20214 changesmanagement 1 · accounts 1 · capital 1 · ownership 1
  • Timothy James Eviston appointed board member
  • Annual report for 2020 published
  • Share capital changed from 42,106 DKK to 42,733 DKK
  • Jesper Ahlmann Funding Andersen is no longer registered as owner
20205 changescapital 2 · management 1 · ownership 1 · name 1
  • Share capital changed from 40,000 DKK to 42,106 DKK
  • Jesper Ahlmann Funding Andersen appointed deputy chair
  • Jesper Ahlmann Funding Andersen registered as owner (5%)
  • Name changed from Hyamedix IVS to Hyamedix ApS
  • Share capital changed from 1,000 DKK to 40,000 DKK
20181 changeaddress 1
  • Moved to Ole Maaløes Vej 3, 2200 København N
201711 changesfounded 1 · management 4 · ownership 6
  • Registered as Hyamedix IVS
  • Michael Foldager Johansen appointed chair of the board
  • Todd Andrew Kenworth appointed chair of the board
  • Michael Foldager Johansen appointed ceo
  • Todd Andrew Kenworth appointed ceo
  • Hyaworth ApS registered as owner (33.33%)
  • Michael Foldager Johansen registered as owner (33.33%)
  • Michael Foldager Johansen is no longer registered as owner
  • Todd Andrew Kenworth registered as owner (50%)
  • Todd Andrew Kenworth is no longer registered as owner
  • Vivida ApS registered as owner (33.33%)

Related companies

Same industry in Frederiksberg

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction